Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Reuven Duer
AddedMar 31, 2024
UpdatedMay 31, 2026
Reuven Duer

Reuven Duer

Co-Founder, PLC Diagnostics

CrunchbaseLinkedIn

Reuven Duer's Career

PLC Diagnostics
PLC Diagnostics

Thousand Oaks, CA, US

Co-Founder
Proactive Diagnostics
Proactive Diagnostics

Thousand Oaks, CA, US

Founder & CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Reuven Duer's Career

PLC Diagnostics
PLC Diagnostics
Angel$183.7k142006Thousand Oaks, CA, US
Co-Founder

Leadership at PLC Diagnostics

Abraham SofaerAbraham SofaerCo-Founder

Similar to PLC Diagnostics

Plasmonic DiagnosticsPlasmonic DiagnosticsColumbia, MO, USDiagnostics, Testingest. 2015Plasmonic DiagnosticsColumbia, MO, US · est. 2015

Missouri-based Plasmonic Diagnostics offers precise solutions for detecting infectious, STDs, and cancer.

Angel · $224.9k1
Prompt DiagnosticsPrompt DiagnosticsBaltimore, MD, USDiagnostic TestsPrompt DiagnosticsBaltimore, MD, US

Prompt Diagnostics: Rapid, affordable, and precise biotech firm for easy-to-use diagnostic testing.

Pre-Seed · $600k2
Gregor DiagnosticsGregor DiagnosticsMadison, WI, USDiagnostic Testsest. 2016Gregor DiagnosticsMadison, WI, US · est. 2016

Gregor Diagnostics, founded in 2016, develops molecular screening tests to determine prostate cancer severity.

Series A · $6.9M8
Molecular DetectionMolecular DetectionWayne, PA, USDiagnostic Testsest. 2007Molecular DetectionWayne, PA, US · est. 2007

Molecular Detection, Inc.: Global provider of rapid molecular diagnostic tests for infectious diseases.

Series A · $8.2M31
Proactive Diagnostics
Proactive Diagnostics
Seed$2M32017Thousand Oaks, CA, US
Founder & CEO· C-Suite · Management

Similar to Proactive Diagnostics

Proxim DiagnosticsProxim DiagnosticsSunnyvale, CA, USPoint-Of-Careest. 2009Proxim DiagnosticsSunnyvale, CA, US · est. 2009

Proxim Diagnostics: Next-gen point-of-care solutions, delivering precise lab tests results instantly to doctors.

Series B · $22.9M8
Prompt DiagnosticsPrompt DiagnosticsBaltimore, MD, USDiagnostic TestsPrompt DiagnosticsBaltimore, MD, US

Prompt Diagnostics: Rapid, affordable, and precise biotech firm for easy-to-use diagnostic testing.

Pre-Seed · $600k2
Predictive Health Diagnostics CompanyPredictive Health Diagnostics CompanyIrvine, CA, USDiagnostic Testsest. 2017Predictive Health Diagnostics CompanyIrvine, CA, US · est. 2017

Predictive Health Diagnostics: Transforming data into intelligent, science-driven diagnostic tests.

Series A · $17.3M29
Accessible DiagnosticsAccessible DiagnosticsGreenville, SC, USMedical Testsest. 2014Accessible DiagnosticsGreenville, SC, US · est. 2014

Accessible Diagnostics: Providing at-home, smartphone-based medical tests for healthier families.

Seed · $219k3

People Similar to Reuven Duer

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoOctavian FlorescuOctavian FlorescuFounder · In DiagnosticsKevin ClarkKevin ClarkCEO · NowdiagnosticsPaul HendersonPaul HendersonCo-Founder · Accelerated Medical DiagnosticsRob DonnellyRob DonnellyCEO · Paratus DiagnosticsFeng ZhangFeng ZhangCo-Founder · Proof DiagnosticsYaniv BejeranoYaniv BejeranoCo-Founder · ImmuneXcite